Prontosan is used for cleaning wounds as well as moistening and lubricating absorbent wound dressings.
The ready-to-use gel contains PHMB and Betaine, the surfactant for the cleansing and moistening of wounds.
“Effective wound care management no longer needs to be limited to within healthcare facility walls,” said Mike Kelly, director of marketing, infection control products for B. Braun Medical, according to a news release. “The 510(k) clearance for OTC use of ProntosanWound Management Gel advances B. Braun’s commitment to infection prevention, helping to provide solutions that positively impact patients’ care — in a physician’s office, acute care setting or in a patient’s home.”
Read the B. Braun news release about Prontosan.
Read more about B. Braun:
– Aesculap Implant Systems, a B. Braun Company, Launches New Patient Education Website
– B. Braun Medical Production Facility in Switzerland Receives FDA Approval
– B. Braun Announces Availability of Large Volume Heparin Infusion Solutions
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
